Slezavit as a Component of Neuroprotective Therapy for Primary Open-Angle Glaucoma. Eura. Med.Res. Per [Internet]. 2022 Jun. 18 [cited 2026 Jun. 19];9:93-5. Available from: https://mail.geniusjournals.org/index.php/emrp/article/view/1726